Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP
- PMID: 17318545
- DOI: 10.1007/s00259-007-0380-y
Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP
Abstract
Purpose: To evaluate a fully automatic computer-assisted diagnostic system for mild dementia with Lewy bodies (DLB), permitting distinction from mild Alzheimer's disease (AD).
Methods: Using 18F-fluorodeoxyglucose and positron emission tomography (FDG-PET), glucose metabolic images were obtained from mild DLB and mild AD patients. Two groups consisting of 16 mild DLB patients and 21 mild AD patients were recruited for diagnostic evaluation between mild DLB and mild AD. The mean age+/-SD of the mild DLB group and the mild AD group was 74.3+/-4.9 and 71.7+/-2.1 years, respectively, and the mean scores of the MMSE for the mild DLB and the mild AD group were 21.7+/-1.9 and 23.1+/-2.1, respectively. A receiver operating characteristic (ROC) analysis was performed to compare the diagnostic performance, in terms of discrimination between DLB and AD, of conventional axial FDG-PET images inspected visually by experts and beginners with that of our fully automatic diagnosis system using the statistical brain mapping method and Z scores obtained with the DLB template.
Results: The diagnostic performance of the automatic system was comparable to that of visual inspection by experts. The area under the ROC curve for the automatic diagnosis system was 0.77. The mean area under the ROC curve for visual inspection by experts and beginners was 0.76 and 0.65, respectively.
Conclusion: The fully automatic differential diagnosis system for distinction between mild DLB and AD showed a similar diagnostic accuracy to visual inspection by experts. It would be a useful diagnostic tool to distinguish mild DLB from mild AD in clinical practice.
Similar articles
-
Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.Eur J Nucl Med Mol Imaging. 2006 May;33(5):575-83. doi: 10.1007/s00259-005-0015-0. Epub 2006 Feb 10. Eur J Nucl Med Mol Imaging. 2006. PMID: 16470370 Clinical Trial.
-
Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.Eur J Nucl Med Mol Imaging. 2009 May;36(5):831-40. doi: 10.1007/s00259-008-1051-3. Epub 2009 Jan 16. Eur J Nucl Med Mol Imaging. 2009. PMID: 19148640
-
Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.Psychiatry Res Neuroimaging. 2016 Mar 30;249:105-12. doi: 10.1016/j.pscychresns.2015.12.007. Epub 2015 Dec 28. Psychiatry Res Neuroimaging. 2016. PMID: 26857415
-
Clinical utility of FDG-PET for the clinical diagnosis in MCI.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1497-1508. doi: 10.1007/s00259-018-4039-7. Epub 2018 Apr 27. Eur J Nucl Med Mol Imaging. 2018. PMID: 29704037 Review.
-
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1509-1525. doi: 10.1007/s00259-018-4035-y. Epub 2018 May 7. Eur J Nucl Med Mol Imaging. 2018. PMID: 29736698 Review.
Cited by
-
Evaluating 2-[18F]FDG-PET in differential diagnosis of dementia using a data-driven decision model.Neuroimage Clin. 2020;27:102267. doi: 10.1016/j.nicl.2020.102267. Epub 2020 Apr 24. Neuroimage Clin. 2020. PMID: 32417727 Free PMC article.
-
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.Brain Imaging Behav. 2012 Dec;6(4):568-83. doi: 10.1007/s11682-012-9208-x. Brain Imaging Behav. 2012. PMID: 23179062 Free PMC article.
-
Urinary incontinence and its functional anatomy in frontotemporal lobar degenerations.Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):605-10. doi: 10.1007/s00259-007-0626-8. Epub 2007 Oct 30. Eur J Nucl Med Mol Imaging. 2008. PMID: 17968544
-
Heuristic scoring method utilizing FDG-PET statistical parametric mapping in the evaluation of suspected Alzheimer disease and frontotemporal lobar degeneration.Am J Nucl Med Mol Imaging. 2021 Aug 15;11(4):313-326. eCollection 2021. Am J Nucl Med Mol Imaging. 2021. PMID: 34513285 Free PMC article.
-
The role of nuclear medicine in central nervous system evaluation.Neuroradiol J. 2025 Jun 25:19714009251345100. doi: 10.1177/19714009251345100. Online ahead of print. Neuroradiol J. 2025. PMID: 40557769 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical